Wolfe Research Initiates Coverage On Apogee Therapeutics with Peer Perform Rating

Benzinga · 5d ago
Wolfe Research analyst Andy Chen initiates coverage on Apogee Therapeutics (NASDAQ:APGE) with a Peer Perform rating.